isoSolutions – About

isoSolutions Marketing & Management Inc.

isoSolutions provides a one-stop shopping service as well as technical support worldwide for nuclear medicine applications including: Radiochemicals, Stable isotopes, Labeled compounds, Sealed sources, Synthesizers and Peptides. We provide a complete range of Radioisotopes, including a Ga-68 Generator, Lu-177, Y-90, a Re-188 Generator, I-131, I-125 and cyclotron products.

These products are complemented by an automated labeling module for development work or preprogrammed syntheses and a complete line of quality control instruments. We also offer consulting services for radiochemistry, grant applications and licensing (CMC sections, INDs, DMFs) in several regions of the globe.

Principles / Values

Company Mission

To offer products, services and solutions to the nuclear medicine, radioisotope research, pharmaceutical and medical device industries and providing a connection to an extensive network of suppliers and resources.

Vision

To become a model organization for delivery of nuclear medicine products, widely recognized for our reliability and excellent customer service.

isoSolutions believes the principles that form the bedrock of a business relationship are critical.

Confidentiality and discretion

Especially within an intimate industry like nuclear medicine, a client can feel confident that a contract with isoSolutions is a matter between isoSolutions and the client, and will not be communicated to competitors or other companies in the industry. A standard mutual non-disclosure agreement will be signed on request, but confidentiality will be respected with or without a formal agreement.

Honesty and integrity

You can expect honest answers to questions and honest assessments of what can be provided by isoSolutions and what cannot be provided. An order will not be accepted unless it can be fulfilled with excellence. Integrity is our most important business principle.

Reliability and timeliness

There are no standard projects for isoSolutions; each project is dictated by the client. For any project, realistic timetables will be provided in advance, and you can rely on the deadlines. If more time is required to provide you with the best information, this will be discussed well in advance of the deadline.

Satisfaction guaranteed

If there is dissatisfaction with a product or delivery, isoSolutions will work hard to “make it right.”

Timeline

2000

Founded isoSolutions Inc. (consulting company).
2001

Founded isoSolutions Marketing & Management Inc.
(product distribution company).
2002

isoSolutions was co-founder of Cyclomedical Applications Group, a company providing medical cyclotron facility services and contract management.
2002

isoSolutions was co-founder of Alpha IICH Inc., a company developing a supply of alpha emitting radioisotopes for radiotherapy.
2003

Established Area Sales Manager for Latin American market.
2005

Formed partnership with Vira Pharma GmbH, a German company that managed the European market while isoSolutions managed the North and South American markets.
2007

Headquarters of isoSolutions moved from Ottawa, Ontario to Vancouver, British Columbia.
2008

Appointed Marketing & Sales Manager, Asia.
2009

Initiated marketing activities in China.
2012

First exhibit at Society of Nuclear Medicine and Molecular Imaging Annual Meeting (Miami Beach).
2013

Hired Executive Assistant to Managing Director.
2013

Established new office space in West End of Vancouver.
2013

Hired Marketing & Sales Manager, Latin America.
2013

isoSolutions sponsors an annual Armstrong-Lepeska Science Marketing Scholarship at Langara College.
2014

Hired Marketing & Sales Manager, Canada/USA.
2014

First exhibit at Canadian Association of Nuclear Medicine (Calgary).
2014

First exhibit at international congress (World Federation of Nuclear Medicine & Biology, Cancun).
2015

First ALASBIMN exhibit (Asociación Latinoamericana de Sociedades de Biología y Medicina Nuclear, Punta del Este).
2015

Established Order Desk.
2015

First exhibit at Brazilian Congress of Nuclear Medicine and Biology (Rio de Janeiro).
2016

isoSolutions celebrates 15th Anniversary.
2016

isoSolutions launches re-designed web site
2017

isoSolutions adds Elysia-raytest to product line
2017

isoSolutions establishes first sales and marketing manager located in United States
2017

A Customer Service Manager is appointed with responsibility for supplier and customer relations, order management, and logistics.
2018

isoSolutions appoints Directors of Marketing & Sales, Customer Service and Administration
2018

GMP grade non-carrier added Lutetium-177 is added to the product portfolio.
2019

A new strategic commercial alliance is established with Fenix Medica to strengthen our presence in Latin America.
2019

A Sales & Marketing Manager for Asia is appointed, expanding the Asian team to three staff.
2019

isoSolutions exhibits at the International Symposium on Targeted Alpha-Therapy.
2019

isoSolutions attends the Chinese National Conference of Nuclear Medicine.
2020

isoSolutions joins the Canadian Nuclear Isotope Council.
2020

Founder started transition to retirement as Strategic Consultant, and new Managing Director was appointed.
2021

A dedicated sales and service team was formed for QC instruments portfolio including Elysia-raytest products.
2021

isoSolutions signs exclusive agreement with QBIOMED to distribute Strontium Sr-89 in Canada.
2021

isoSolutions signs exclusive agreement with Isotopia to distribute Lutetium Lu-177 in Canada.

Global Network

A multilingual staff located throughout the world assists with product sourcing, identification of suppliers for nuclear medicine needs, and marketing and sales of products wherever business is intended to be done.